The Operator's Guide to
Ketamine Therapy for Mental Health
There is a particular kind of silence that comes after years of carrying something you cannot put down. It does not look like a breakdown. It looks like function. You still show up. You still perform. You still do the job. But the sleep is gone, the edge is duller than it used to be, the fuse is shorter, and somewhere behind the discipline there is a weight that SSRIs and talk therapy have not been able to touch.
If that sounds familiar, you are not alone and you are not broken. You may simply be dealing with a condition that traditional treatments were not designed to reach. Ketamine therapy represents a fundamentally different approach to treatment-resistant depression, PTSD, anxiety, and other mental health conditions that have not responded to conventional medication. T1Rx offers ketamine therapy because our team understands what operational trauma looks like from the inside, and we know that the people who carry the heaviest loads are often the last ones to ask for help.
Ketamine and PTSD:
What the Research Shows
Post-traumatic stress disorder affects approximately 6-7% of U.S. adults at some point in their lives, with significantly higher rates among combat veterans, first responders, and law enforcement. Standard treatments include cognitive behavioral therapy (CBT), prolonged exposure therapy, EMDR, and SSRI medications. These work for many people. They do not work for everyone. A review published in the journal FOCUS by the American Psychiatric Association examined the state of ketamine research for PTSD and found that a single intravenous dose of ketamine facilitated rapid reduction of PTSD symptoms. Repeated IV ketamine administration significantly improved symptoms compared to midazolam (a control sedative) in a predominantly civilian sample.
A 2025 University of Florida study surveying real-world patients prescribed ketamine in community clinics found that over 80% of those with PTSD reported sleeping better, feeling less anxious, experiencing fewer trauma triggers, and enjoying a better overall quality of life after treatment. Patients described ketamine as a "lifesaving medication." The study also found that patients with PTSD, despite starting with more severe depression and anxiety, improved just as much as patients without PTSD.
Research into combining ketamine with psychotherapy is particularly promising. The theory is that ketamine's rapid neuroplasticity effects create a window during which the brain is more receptive to therapeutic processing of traumatic memories. Several pilot studies have combined ketamine infusions with prolonged exposure therapy and mindfulness-based approaches, showing significant symptom reduction that may outlast ketamine administered alone.
What makes this particularly relevant for the T1Rx community is the specific nature of operational trauma. Combat veterans, first responders, and law enforcement officers often carry trauma that is layered, chronic, and compounded by years of additional exposure. A single traumatic event is devastating on its own. Repeated exposure to violence, death, moral injury, and hyper-responsibility creates a neurological pattern that is qualitatively different from civilian trauma. Standard PTSD treatments were largely developed for single-incident trauma. Ketamine's ability to address the neurobiological underpinnings of chronic, complex trauma is what makes it a meaningful option for this population.
The stigma around mental health treatment in military and first-responder communities is real, though slowly improving. Men who would never hesitate to treat a physical injury often resist acknowledging a psychological one. T1Rx understands this dynamic because our team has lived it. The language we use, the environment we create, and the protocols we follow are designed for people who need effective treatment without the condescension or the clinical sterility that makes many men avoid care altogether.
What a Ketamine Treatment Protocol Looks Like
Ketamine therapy protocols vary by provider and clinical setting, but the general framework follows a structured approach:
The initial phase typically involves 6-8 infusions over 2-4 weeks. The American Society of Anesthesiologists published updated guidance in February 2025 emphasizing that ketamine for mental health should only be prescribed and administered by trained healthcare professionals with appropriate monitoring capabilities. Dosing is typically subanesthetic (much lower than surgical anesthesia), administered intravenously over 40-60 minutes while vital signs are continuously monitored.
During an infusion, patients commonly experience dissociative effects: altered perception of time and space, a sense of detachment from the body, and sometimes vivid mental imagery. These effects are temporary, typically resolving within 1-2 hours after the infusion ends. Some patients find the experience uncomfortable initially but report that subsequent sessions become more manageable as they know what to expect.
After the initial series, maintenance infusions are scheduled based on individual response. Some patients maintain benefit with monthly infusions. Others may go longer between sessions. The goal is to find the minimum effective frequency that sustains symptom improvement.
Esketamine (Spravato): The FDA-Approved Option
Esketamine is a nasal spray derived from ketamine that received FDA approval in 2019 for treatment-resistant depression and, subsequently, for major depressive disorder with suicidal ideation. It is administered under medical supervision in a certified healthcare setting. Patients self-administer the nasal spray and are then monitored for at least two hours. The treatment schedule typically involves twice-weekly administration for the first month, once weekly for the second month, and then biweekly or as needed thereafter. Because esketamine is FDA-approved, it is more likely to be covered by insurance than off-label IV ketamine infusions.
Safety, Side Effects, and Why Medical Supervision Is Non-Negotiable
Ketamine is a controlled substance (Schedule III). It has a well-established safety profile when administered at appropriate doses under medical supervision. Common side effects during infusion include nausea, dizziness, elevated blood pressure, dissociation, and visual disturbances. These effects are transient and typically resolve within hours.
The risks increase significantly outside of medical settings. At-home ketamine prescriptions from telehealth companies that ship medication without adequate evaluation or monitoring have raised serious concerns in the medical community. The ASA's 2025 guidance specifically addressed this, recommending that ketamine should be administered at the minimum dose necessary, in settings with appropriate safety monitoring, and with a defined therapeutic endpoint. T1Rx follows these standards without exception.
Ketamine at T1Rx: Why the Provider Matters
Most ketamine clinics are run by anesthesiologists or psychiatrists who understand the pharmacology but may not understand the patient sitting in front of them. T1Rx is different because we were built by people who have lived on the other side of operational stress. The Special Forces medics who founded T1Rx have managed trauma in environments where conventional medicine is not available, where the people who need help the most are the least likely to ask for it, and where the stigma around mental health treatment has historically been a barrier to care.
That lived experience shapes how T1Rx delivers ketamine therapy. The evaluation process is thorough but not clinical in a way that feels impersonal. The treatment environment is designed for people who need to feel safe and respected. The follow-up is built around accountability and progress, not just symptom checklists. If you have been carrying something that conventional treatments have not been able to reach, T1Rx is equipped to have that conversation.
Ketamine therapy can be complemented by other T1Rx protocols. Sleep Shield supports the restorative sleep that is critical for mental health recovery. TRT addresses hormonal imbalances that contribute to mood dysregulation. The T1Rx approach is to treat the whole system, not just one symptom in isolation.
Frequently Asked Questions
Is ketamine therapy addictive?
At the subanesthetic doses used in therapeutic settings, the risk of addiction is low when treatment is administered under medical supervision with defined protocols and treatment endpoints. Ketamine does have abuse potential at recreational doses, which is why medical oversight, controlled dosing, and monitoring for signs of misuse are essential components of any responsible ketamine program. T1Rx follows the ASA guidance that ketamine should be prescribed at the minimum effective dose with a defined treatment course.
How quickly will I feel the effects?
Many patients report noticeable improvement in mood and reduction in intrusive thoughts within 24-72 hours of the first infusion. The full benefit of the initial treatment series (6-8 infusions) typically becomes apparent over 2-3 weeks. Response varies significantly between individuals. Some experience dramatic improvement quickly. Others require the full series before meaningful change occurs.
Will my employer or military service know I am receiving ketamine therapy?
T1Rx maintains strict confidentiality for all patients. Your medical records are protected by HIPAA. Whether and how to disclose mental health treatment to an employer or military command is a personal decision that depends on your specific circumstances and applicable policies. T1Rx providers can discuss this with you during your evaluation.
Can I drive after a ketamine session?
No. You should not drive, operate heavy machinery, or make important decisions for at least 12-24 hours after a ketamine session. You will need someone to drive you home from your appointment. T1Rx will provide specific post-treatment guidelines during your evaluation.
Does insurance cover ketamine therapy?
FDA-approved esketamine (Spravato) nasal spray is more commonly covered by insurance for treatment-resistant depression. Off-label IV ketamine infusions are typically not covered. T1Rx can provide information about costs and payment options during your consultation. Reach out through the contact form at t1rx.com/contact or call 877-GET-T1RX for details.
What is the difference between ketamine and psychedelic therapy?
Ketamine is a dissociative anesthetic, not a classic psychedelic like psilocybin or MDMA. While it can produce altered states of consciousness at therapeutic doses, its primary mechanism is NMDA receptor antagonism and the resulting neuroplasticity, not the serotonin-mediated effects of traditional psychedelics. Ketamine is the only substance in this category that is currently legal for off-label therapeutic use in the United States. Psilocybin and MDMA remain Schedule I substances at the federal level, though research is ongoing.
Take the Next Step
Asking for help requires more courage than most people will ever understand. If you are carrying something that traditional treatments have not been able to lift, ketamine therapy may be the intervention that changes the trajectory. T1Rx is built by people who understand the weight and respect the decision.
Reach out through our contact form at t1rx.com/contact, call 877-GET-T1RX, or chat live on the website. Every conversation is confidential. Every evaluation is thorough. The only step that matters right now is the first one.
